Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yech'an Laizet"'
Autor:
Julie Blanchi, Sofiane Taleb, Arnaud Bayle, Benjamin Verret, Maud Toulmonde, Mariella Spalato‐ceruso, Paul Dubos, Yech'an Laizet, Melissa Alame, Emmanuel Khalifa, Antoine Italiano
Publikováno v:
Cancer Communications, Vol 43, Iss 9, Pp 1051-1054 (2023)
Externí odkaz:
https://doaj.org/article/159023a74aaa4424a218e1fc639d880e
Autor:
Yu Fu, Marie Karanian, Raul Perret, Axel Camara, François Le Loarer, Myriam Jean-Denis, Isabelle Hostein, Audrey Michot, Françoise Ducimetiere, Antoine Giraud, Jean-Baptiste Courreges, Kevin Courtet, Yech’an Laizet, Etienne Bendjebbar, Jean Ogier Du Terrail, Benoit Schmauch, Charles Maussion, Jean-Yves Blay, Antoine Italiano, Jean-Michel Coindre
Publikováno v:
npj Precision Oncology, Vol 7, Iss 1, Pp 1-9 (2023)
Abstract Risk assessment of gastrointestinal stromal tumor (GIST) according to the AFIP/Miettinen classification and mutational profiling are major tools for patient management. However, the AFIP/Miettinen classification depends heavily on mitotic co
Externí odkaz:
https://doaj.org/article/75a03086c3eb458f956500ff25fbf5f3
Gene expression profiling improves prognostication by nomogram in patients with soft‐tissue sarcomas
Autor:
Amandine Crombé, Mariella Spalato‐Ceruso, Audrey Michot, Yech'an Laizet, Carlo Lucchesi, Maud Toulmonde, Kevin Bourcier, François Le Loarer, Antoine Italiano
Publikováno v:
Cancer Communications, Vol 42, Iss 6, Pp 563-566 (2022)
Externí odkaz:
https://doaj.org/article/2159bf1e91ae4b21931610dda67e2a67
Autor:
Sophie Cousin, Emmanuel Khalifa, Amandine Crombe, Yech’an Laizet, Carlo Lucchesi, Maud Toulmonde, Sylvestre Le Moulec, Céline Auzanneau, Isabelle Soubeyran, Antoine Italiano
Publikováno v:
Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-3 (2018)
Abstract Preclinical data have shown that ERBB2 activating mutations are responsive to HER2 tyrosine kinase inhibitors. The aim of this study is to characterize the landscape of ERBB2 mutations in solid tumors and the potential efficacy of ERBB2 targ
Externí odkaz:
https://doaj.org/article/e90377a4ce3e44979c154ba49dd1440d
Autor:
yu fu, Marie Karanian, Raul Perret, Axel Camara, François Le Loarer, Myriam Jean-Denis, Isabelle Hostein, Audrey Michot, Françoise Ducimetiere, Antoine Giraud, Jean-Baptiste Courreges, Kevin Courtet, Yech'an LAIZET, Etienne Bendjebbar, Jean Ogier Du Terrail, Benoit Schmauch, Charles Maussion, Jean Yves Blay, Antoine Italiano, Jean-Michel Coindre
Background. Most gastrointestinal stromal tumors (GIST) have activating mutations of KITor PDGFRA genes and imatinib has proven effective in palliative and adjuvant situations. Risk assessment according to the AFIP/Miettinen classification and mutati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54d5bfe786a7a5051f433069efd2040c
https://doi.org/10.21203/rs.3.rs-2080092/v1
https://doi.org/10.21203/rs.3.rs-2080092/v1
